Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Norepinephrine Infusion Combined With Goal-directed Fluid Therapy Reduces Delayed Graft Function Incidence in Patients Undergoing Kidney Transplantations: a Randomized Multicenter Clinical Trial

NCT06367205 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT06367205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06367205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Norepinephrine Infusion Combined With Goal-directed Fluid Therapy Reduces Delayed Graft Function Incidence in Patients Undergoing Kidney Transplantations: a Randomized Multicenter Clinical Trial
Lead sponsor
RenJi Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
March 1, 2024
Completion date
June 30, 2026
Enrollment
380 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

delayed graft function, end stage renal disease, kidney transplantation